INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1.42 Cr | ₹-4.58 Cr | ₹0.53 Cr | ₹2.91 Cr | ₹0.22 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDO US BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1.42 Cr |
| Mar2024 | ₹-4.58 Cr |
| Mar2023 | ₹0.53 Cr |
| Mar2022 | ₹2.91 Cr |
| Mar2021 | ₹0.22 Cr |
How is Cash Flow from Operating Activities of INDO US BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.42 Cr | Positive | |
| Mar2024 | ₹-4.58 Cr | Negative | |
| Mar2023 | ₹0.53 Cr | -81.91 | |
| Mar2022 | ₹2.91 Cr | 1,192.44 | |
| Mar2021 | ₹0.22 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹199.3 Cr | -12.3% | -26.6% | -49% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,634.6 Cr | -3.3% | -13.1% | -10.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,168.6 Cr | 6.8% | -10.7% | -24.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,709.7 Cr | -2.3% | -14.4% | -21.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹861.0 Cr | -0.5% | -9.2% | -39.7% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹336.5 Cr | 2.8% | -19.9% | -35.8% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -12.3% |
-26.6% |
-49% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses